Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Devereux, T. R.
Right arrow Articles by Anderson, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devereux, T. R.
Right arrow Articles by Anderson, M. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 Oxford University Press

other

Low frequency of H-ras mutations in hepatocellular adenomas and carcinomas and in hepatoblastomas from B6C3F1 mice exposed to oxazepam in the diet

Theodora R. Devereux 1 3, Catherine M. White 1, Robert C. Sills 2, John R. Bucher 2, Robert R. Maronpot 1 and Marshall W. Anderson 1

1Environmental Carcinogenesis Program
2Environmental Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park NC 27709, USA

3To whom correspondence should be addressed

Oxazepam has been the subject of recent toxicological and carcinogenesis studies because it is a commonly prescribed tranquilizer and has been shown to cause tumors in rodents. In this study, male and female B6C3F1 mice receIved 0,125, 2500 or 5000 p.p.m. oxazepam in the diet for up to 2 years. Hepatocellular adenomas and carcinomas, as well as hepatoblastomas, which developed in these mice, were examined for the presence of activated ms proto-oncogenes. DNA was Isolated from 20 or more tumors from each exposure group and analyzed by oligonudeotide hybridiza tion, single-stranded conformation polymorphism analysis and direct sequencing of PCR-ampllfied H-ms gene fragments for codon 61 mutations. Thirteen of 37 (35%) hepatocellular adenomas and carcinomas from the 125 p.p.m. exposure group had mutations in codon 61, while mutations were detected in only 2 of 25 or 8% of the liver tumors from the 2500 p.p.m. exposure group and none of the 22 tumors from the 5000 p.p.m. group. This compares to 63% of 126 historIcal control liver tumors and 55% of 20 liver tumors from unexposed B6C3F1 mice in this study. In addition, 12 hepatoblastomas from the two high dose groups were examined for H-ras mutations at codon 61, but none were detected. No tumor DNAs from any of the exposure groups tested had mutations In codons 12, 13 or 117 of the H-ras gene or codons 12 or 13 of the K-ras gene, the other known hotspots for ras activation in mouse liver tumors. These results, together with those from the National Toxicology Program study showing no evidence of cytotoxicity or genotoxicity by oxazepam, suggest that oxazepam preferentially promotes cells that have activating lesions other than ras.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
M. Iida, C. H. Anna, W. M. Holliday, J. B. Collins, M. L. Cunningham, R. C. Sills, and T. R. Devereux
Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogens
Carcinogenesis, March 1, 2005; 26(3): 689 - 699.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
Y. Kim, R. C. Sills, and C. D. Houle
Overview of the Molecular Biology of Hepatocellular Neoplasms and Hepatoblastomas of the Mouse Liver
Toxicol Pathol, January 1, 2005; 33(1): 175 - 180.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
R.R. Maronpot, G. Flake, and A. J. Huff
Relevance of Animal Carcinogenesis Findings to Human Cancer Predictions and Prevention
Toxicol Pathol, January 1, 2004; 32(1_suppl): 40 - 48.
[Abstract] [PDF]

Home page
 CarcinogenesisHome page
M. Iida, C. H. Anna, J. Hartis, M. Bruno, B. Wetmore, J. R. Dubin, S. Sieber, L. Bennett, M. L. Cunningham, R. S. Paules, et al.
Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643
Carcinogenesis, April 1, 2003; 24(4): 757 - 770.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. H. Anna, R. C. Sills, J. F. Foley, P. S. Stockton, T.-V. Ton, and T. R. Devereux
{beta}-Catenin Mutations and Protein Accumulation in All Hepatoblastomas Examined from B6C3F1 Mice Treated with Anthraquinone or Oxazepam
Cancer Res., June 1, 2000; 60(11): 2864 - 2868.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
B.S. Shane, J.G. deBoer, B.W. Glickman, and M.L. Cunningham
Oxazepam is mutagenic in vivo in Big Blue(R) transgenic mice
Carcinogenesis, July 1, 1999; 20(7): 1315 - 1321.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
H.-H. L. Hong, T. R. Devereux, J. H. Roycroft, G. A. Boorman, and R. C. Sills
Frequency of ras Mutations in Liver Neoplasms from B6C3FX Mice Exposed to Tetrafluoroethylene for Two Years
Toxicol Pathol, September 1, 1998; 26(5): 646 - 650.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.